Novel therapeutic approaches in the treatment of solitary fibrous tumors: A call for a combination therapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F20%3A10412407" target="_blank" >RIV/00216208:11110/20:10412407 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/20:10412407 RIV/00064203:_____/20:10412407
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=UPnjbQ31gi" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=UPnjbQ31gi</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/cncr.33055" target="_blank" >10.1002/cncr.33055</a>
Alternative languages
Result language
angličtina
Original language name
Novel therapeutic approaches in the treatment of solitary fibrous tumors: A call for a combination therapy
Original language description
A solitary fibrous tumor (SFT) is a rare mesenchymal tumor with a high risk of local recurrence and a metastatic potential. Because of the rarity of the disease, the data regarding possible nonsurgical treatment options are limited. Until recently, most extensive reports regarding nonsurgical SFT treatment were based on case reports. Although SFTs present rare diseases and may have a benign biological nature, local recurrence and metastatic behavior are also highly prevalent. Based on the limited data, we aim to highlight that similarly to soft-tissue sarcomas, radiotherapy, targeted therapy, and immunotherapy should become part of therapeutic algorithms in SFTs. Moreover, clinical testing of other immune checkpoint inhibitors is urgently needed, and only close interdisciplinary cooperation between surgical and nonsurgical institutions can introduce patients with SFTs to novel immunotherapeutic approaches, such as adoptive T-cell transfer and chimeric antigen receptor T-cell immunotherapy.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cancer
ISSN
0008-543X
e-ISSN
—
Volume of the periodical
126
Issue of the periodical within the volume
17
Country of publishing house
US - UNITED STATES
Number of pages
2
Pages from-to
4068-4069
UT code for WoS article
000545029900001
EID of the result in the Scopus database
2-s2.0-85087420076